Physician profile
Beata Smyk
NPI 1316289259
$2,032.02
in general payments reported to CMS, 2019-2025
18 companies · $1,422 in 2025
The $1,422 reported for 2025 was more than what 90% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $26.24 · 2024: $583 · 2025: $1,422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,828 · Education: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,828.05 |
| Education | $203.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $329.69 | 2024-2025 | Ojjaara, Jemperli |
| Merck Sharp & Dohme LLC | $289.54 | 2024-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Incyte Corporation | $287.73 | 2025 | Pemazyre, Jakafi, Pemazyre |
| Pfizer INC. | $239.95 | 2025 | |
| Daiichi Sankyo INC. | $187.07 | 2024-2025 | Enhertu |
| Janssen Biotech, INC. | $161.98 | 2024-2025 | Imbruvica, Erleada |
| Novartis Pharmaceuticals Corporation | $110.25 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $89.05 | 2024-2025 | Lynparza |
| Stemline Therapeutics INC. | $79.41 | 2024-2025 | Orserdu |
| Seagen INC. | $41.99 | 2024 | |
| Sobi, INC | $36.36 | 2024 | |
| Lilly USA, LLC | $29.76 | 2025 | Omvoh |
| Alexion Pharmaceuticals, INC. | $28.39 | 2024 | Ultomiris |
| Puma Biotechnology, INC. | $27.52 | 2025 | |
| Amgen INC. | $26.24 | 2023 | Repatha |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $23.27 | 2024 | |
| Genzyme Corporation | $22.45 | 2024 | |
| Genentech USA, INC. | $21.37 | 2025 | Itovebi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beata Smyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.